摘要
背景:表观遗传调节(如组蛋白修饰)因其修饰基因而不改变DNA序列的能力而日益受到重视。已经显示许多生物活性化合物改变各种癌症中的遗传和表观遗传学特征。 Sulforaphane(SFN)是十字花科蔬菜中发现的异硫氰酸盐,如羽衣甘蓝,卷心菜和西兰花芽,是迄今为止最有效的组蛋白去乙酰化酶抑制剂(HDACis)之一。最近,已经确定HDAC在调节微RNA(miR)和人端粒酶逆转录酶(hTERT)中可能发挥重要作用。 目的:我们的研究目标是确定异常的HDAC,hTERT和miR水平是否可以通过在结肠直肠癌(CRC)细胞中采用基于饮食的新方法来调节。 方法:采用MTT法,细胞密度实验,实时逆转录 - 聚合酶链反应(RT-PCR),细胞周期分析,western-blot实验,HDAC活性实验和免疫组织化学方法检测SFN对CRC细胞的体外表观遗传效应。 teloTAGGG端粒酶PCR Elisa分析。 结果:我们在HCT116和RKO CRC细胞中证明了生理相关浓度SFN的抑制作用,并首次表明SFN处理降低了CRC细胞的细胞密度,显着抑制了细胞活力并诱导细胞凋亡。我们还发现实际剂量的SFN显着下调CRC细胞中的致癌miR-21,HDAC和hTERT mRNA,蛋白质和酶水平。 结论:我们的研究表明HDAC,hTERT和miR-21的调控是延缓和/或预防CRC的有希望的方法,并且可以通过在十字花科蔬菜中食用SFN来完成。
关键词: Sulforaphane,表观遗传学,组蛋白去酰化酶,组蛋白去质酶抑制剂,人端粒酶逆转录酶,miR-21。
Current Cancer Drug Targets
Title:Mechanisms for the Inhibition of Colon Cancer Cells by Sulforaphane through Epigenetic Modulation of MicroRNA-21 and Human Telomerase Reverse Transcriptase (hTERT) Down-regulation
Volume: 18 Issue: 1
关键词: Sulforaphane,表观遗传学,组蛋白去酰化酶,组蛋白去质酶抑制剂,人端粒酶逆转录酶,miR-21。
摘要: Background: Epigenetic modulations such as histone modifications are becoming increasingly valued for their ability to modify genes without altering the DNA sequence. Many bioactive compounds have been shown to alter genetic and epigenetic profiles in various cancers. Sulforaphane (SFN), an isothiocyanate found in cruciferous vegetables such as kale, cabbage and broccoli sprouts, is one of the most potent histone deacetylase inhibitors (HDACis) to date. Recently, it has been identified that HDACis may play a vital role in regulating microRNAs (miRs) and human telomerase reverse transcriptase (hTERT).
Objective: The aim of our study was to identify if aberrant HDAC, hTERT and miR levels could be regulated through novel dietary-based approaches in colorectal cancer (CRC) cells.
Methods: We evaluated the in vitro epigenetic effects of SFN on CRC cells by MTT assay, cellular density assay, real-time reverse transcriptase-polymerase chain reaction (RT-PCR), cell cycle analysis, western-blot assay, HDAC activity assay and teloTAGGG telomerase PCR Elisa assay.
Results: We demonstrated the inhibitory effects of physiologically relevant concentrations of SFN in both HCT116 and RKO CRC cells, and showed for the first time that SFN treatment decreased cell density, significantly inhibited cell viability and induced apoptosis in CRC cells. We also found that practical doses of SFN significantly down-regulated oncogenic miR-21, HDAC and hTERT mRNA, protein and enzymatic levels in CRC cells.
Conclusion: Our studies suggest that the regulation of HDAC, hTERT and miR-21 is a promising approach for delaying and/or preventing CRC and may be accomplished via the consumption of SFN in cruciferous vegetables.
Export Options
About this article
Cite this article as:
Mechanisms for the Inhibition of Colon Cancer Cells by Sulforaphane through Epigenetic Modulation of MicroRNA-21 and Human Telomerase Reverse Transcriptase (hTERT) Down-regulation, Current Cancer Drug Targets 2018; 18 (1) . https://dx.doi.org/10.2174/1568009617666170206104032
DOI https://dx.doi.org/10.2174/1568009617666170206104032 |
Print ISSN 1568-0096 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5576 |
Call for Papers in Thematic Issues
Innovative Cancer Drug Targets: A New Horizon in Oncology
Cancer remains one of the most challenging diseases, with its complexity and adaptability necessitating continuous research efforts into more effective and targeted therapeutic approaches. Recent years have witnessed significant progress in understanding the molecular and genetic basis of cancer, leading to the identification of novel drug targets. These include, but ...read more
Role of Immune and Genotoxic Response Biomarkers in Tumor Microenvironment in Cancer Diagnosis and Treatment
Biological biomarkers have been used in medical research as an indicator of a normal or abnormal process inside the body, or of a disease. Nowadays, various researchers are in process of exploring and investigating the biological markers for the early assessment of cancer. DNA Damage response (DDR) pathways and immune ...read more
The Impact of Cancer Neuroscience on Novel Brain Cancer Treatment
Brain cancer remains one of the most challenging malignancies due to its complexity and resistance to conventional therapies. Recent advancements in cancer neuroscience have transformed our understanding of the brain's tumor microenvironment, offering promising insights into novel treatments. By studying the intricate interactions between cancer cells and the nervous system, ...read more
Unraveling the Tumor Microenvironment and Potential Therapeutic Targets: Insights from Single-Cell Sequencing and Spatial Transcriptomics
This special issue will focus on unraveling the complexities of the tumor microenvironment (TME) and identifying key biomarkers for potential therapeutic targets using advanced multi-omics techniques, such as single-cell sequencing and spatial transcriptomics. We seek original research and comprehensive reviews that investigate the heterogeneity and dynamics of the TME, emphasizing ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Plasminogen Activator System and Vascular Disease
Current Vascular Pharmacology Is 5-ASA Still the Treatment of Choice for Ulcerative Colitis?
Current Drug Targets Star Graphs of Protein Sequences and Proteome Mass Spectra in Cancer Prediction
Current Proteomics Pharmacological Modulation of Microparticle Release: New Strategies for the Management of Atherothrombotic Vascular Disorders
Current Pharmaceutical Design Novel Epigenetic Targets in Lymphoproliferative Disorders
Current Cancer Drug Targets Patent Selections
Recent Patents on Anti-Cancer Drug Discovery Novel Small Molecule Inhibitors of Programmed Cell Death (PD)-1, and its Ligand, PD-L1 in Cancer Immunotherapy: A Review Update of Patent Literature
Recent Patents on Anti-Cancer Drug Discovery Nanotechnology-based Assays for the Detection of Cancer through Sputum
Current Analytical Chemistry Editorial [ Hot Topic: Wnt Signaling (Guest Editor: Rashna D. Balsara) ]
Current Drug Targets Anti-Tuberculosis Drug Induced Hepatotoxicity and Genetic Polymorphisms in Drug-metabolizing Genes
Current Pharmacogenomics Xanthohumol: A Metabolite with Promising Anti-Neoplastic Potential
Anti-Cancer Agents in Medicinal Chemistry Natural Products as a Source of Protein Kinase Activators and Inhibitors
Current Topics in Medicinal Chemistry Current Status and Future Perspectives of Chemoprevention in Head and Neck Cancer
Current Cancer Drug Targets Invasomes for Enhanced Delivery through the Skin: Evaluation of Systems to Meet with Clinical Challenges
Pharmaceutical Nanotechnology Design of Nanodrug Delivery Systems for Tumor Bone Metastasis
Current Pharmaceutical Design Harnessing the Therapeutic Potential of Antimicrobial Peptides for Cancers: State of the Art
Current Topics in Medicinal Chemistry EPO Relies upon Novel Signaling of Wnt1 that Requires Akt1, FoxO3a,GSK-3β, and β-Catenin to Foster Vascular Integrity during Experimental Diabetes
Current Neurovascular Research Influence of Aldo-keto Reductase 1C3 in Prostate Cancer - A Mini Review
Current Cancer Drug Targets The Function of LncRNA FTX in Several Common Cancers
Current Pharmaceutical Design A Mini-review on the Chemical Composition, Extraction and Isolation Techniques, and Pharmacological Activity of <i>Rosmarinus officinalis L</i>.
Current Chinese Science